市场调查报告书
商品编码
1245711
2022-2028 年全球内窥镜流体管理市场规模、份额、行业趋势分析报告,按应用、产品、最终用户、地区展望和预测Global Endoscopy Fluid Management Market Size, Share & Industry Trends Analysis Report By Application, By Product, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
在预测期内,内窥镜流体管理的全球市场规模预计将以 7.2% 的复合年增长率增长,到 2028 年将达到 9.7 亿美元。
液体吸收增加与宫内压高、子宫肌层深、宫内压高和子宫大有关。 进行泌尿科内窥镜检查以诊断与泌尿道相关的问题。 内窥镜检查有两种类型:输尿管镜检查和膀胱镜检查。 膀胱镜检查膀胱和尿道内部,输尿管镜检查输尿管和肾臟内部。
技术进步使侵入性泌尿外科手术成为可能。 它的特点是并发症风险低,手术效率高。 例如,从尿道取出肾结石的手术。 一种医用泵,可在内窥镜手术期间在压力下将流体输送到手术区域。 关节镜有助于治疗前交叉韧带损伤,这是职业运动中的一种主要损伤。 流体管理系统压力设置得尽可能低或根据能见度要求设置。
COVID-19 影响分析
COVID-19 给世界各地的医疗保健系统带来压力。 这种流行病改变了医疗设备製造商和医疗保健提供者处理内窥镜流体管理系统的方式。 COVID-19 大流行影响了许多专科医师和程序相关领域,例如胃肠病学。 重组了大量医院和诊所,以提高其为诊断出患有 COVID-19 的患者提供服务的能力。 此外,预计这些内窥镜手术中有很大一部分会因封锁而受到影响,这将对内窥镜流体管理市场的增长产生不利影响。
市场增长因素
由于微创手术的增多
与传统的开放手术相比,微创手术的创伤要小得多。 使用传统腹腔镜器械进行的手术具有创伤性和復杂性。 然而,在微创手术中,通过一个小切口插入腹腔镜摄像机,并使用小型专用仪器进行手术。 此外,疼痛更少,患者恢復得更快。 更快的恢復、更小的切口、更高的准确性、更短的住院时间、更少的疤痕和更少的疼痛使得这些手术越来越受欢迎。 此外,这些医疗显示器甚至可以提供细胞和组织中最细微的差异,确保出色的可视性并实现快速和精确的手术。 这支持了本地市场的增长。
胃肠道癌患者数量增加
我们发现胃肠道癌症的负担正在转移到发展中经济体,这些国家通常缺乏医疗资源来应对日益增加的患病率。 预计五种主要胃肠道癌症类型中每一种的新病例和死亡人数都会增加。 这种癌症还与感染、吸烟、节食、缺乏运动、饮酒和肥胖有关。 胃肠道癌症病例的增加,尤其是在新兴国家,将促进内窥镜液体管理的使用,这将推动预测期内的市场扩张。
市场製约因素
内窥镜检查的替代方法
接受内窥镜检查的患者通常会被麻醉或轻度镇静,因为这对许多患者来说可能会感到不舒服和疼痛。大多数接受扫描的人不需要镇静剂。 此外,几乎任何年龄的人都可以进行 CT 扫描,而内窥镜检查主要针对成年人。 由于 CT 扫描无痛且不需要镇静,因此它们是内窥镜检查的潜在替代品,预计内窥镜检查会阻碍液体管理的市场增长。
产品展望
根据产品,内窥镜流体管理市场分为系统和配件。 在 2021 年的内窥镜流体管理市场中,配件部分占据了很大的收入份额。 这是因为这些附件用于治疗和组织样本采集。 内窥镜具有通道,医生可以通过这些通道将工具插入患者体内。 这些工具包括用于采集组织样本的柔性镊子、用于去除可疑生长物的活检钳、用于采集细胞样本的细胞学刷以及用于去除体内缝线的缝线去除钳。我有。
应用展望
根据应用,内窥镜流体管理市场分为腹腔镜、宫腔镜和其他。 到 2021 年,腹腔镜细分市场将在内窥镜流体管理市场中占据最高的收入份额。 这是由于越来越多的腹腔镜手术。 许多人现在选择微创手术进行诊断和治疗。 此外,全球老龄化人口正在增加,进一步增加了对内窥镜流体管理系统的需求。 预计这些因素将在预测期内推动该细分市场的增长。
最终用户视角
按最终用户划分,内窥镜流体管理市场分为医院、诊所和其他。 医院部门将在 2021 年以最大的收入份额引领内窥镜流体管理市场。 这是由于在此类医疗机构中接受大量外科手术的患者数量不断增加。 内窥镜手术正在增加,先进的医院正在发展。 此外,许多政府机构正着力加强手术能力。 预计这些因素将加速该行业的扩张。
区域展望
按地区分析了北美、欧洲、亚太地区和 LAMEA 的内窥镜液体管理市场。 到 2021 年,北美地区将占据内窥镜流体管理市场的最高收入份额。 这是由于这些系统提供的帮助可维持正确的压力以减少内窥镜手术期间的内腔出血。 高科技设备的使用提高了治疗的依从性。 该地区还拥有高技能的医疗队伍、高科技技术和强大的医疗保健基础设施。 此外,政府为进一步加强该行业而出台的多项政策预计将提高该地区医疗器械的利用率并促进市场增长。
市场进入者采取的主要策略是产品发布。 发表在 Cardinal Matrix 上的一项分析表明,美敦力 PLC 是内窥镜液体管理市场的先驱。 Olympus Corporation、Stryker Corporation 和 Hologic, Inc. 等公司是内窥镜流体管理市场的领先创新者。
The Global Endoscopy Fluid Management Market size is expected to reach $970 Million by 2028, rising at a market growth of 7.2% CAGR during the forecast period.
Endoscopy fluid management is a medical device that assists in managing fluids during endoscopic procedures. These systems generally contain a suction device, a fluid collection unit, and a disposable fluid system. the fluid collection unit collects and stores fluid during endoscopic procedures. The suction device are used to remove fluids from the patient's body and carry them to the fluid collection unit. The disposable fluid system treats and disposes of the collected fluids in a manner that is environment friendly.
An endoscopy fluid management system is required in all endoscopy procedures, including laparoscopy, arthroscopy, hysteroscopy, and urology. A laparoscopy is a surgical, diagnostic procedure conducted utilizing laparoscopy and aids in evaluating the organs inside the abdomen. It's a minimally invasive procedure that needs only small incisions. In hysteroscopy, systemic absorption of the uterine distension fluid occurs majorly through disrupted endometrial and myometrial venous sinuses due to the pressure gradient between the uterine cavity and open vessels or sinuses.
The increased fluid absorption is linked with high intrauterine pressure, deep myometrial penetration, higher intrauterine pressure, and large uteri. Urology endoscopies are done to diagnose the issues related to the urinary tract. Endoscopies come in two forms one is ureteroscopy, and the other is cystoscopy. A cystoscopy utilizes a cystoscope to look inside the bladder and urethra, whereas a ureteroscopy utilizes a ureteroscopy to look inside the ureters and kidneys.
With technological advancements, it is possible to conduct invasive urological surgeries. Lower risk of complications and high efficiency characterizes them. For instance, the removal of kidney stones through the urethra. A medical pump is designed to deliver fluid under pressure to an operating area during endoscopy. Arthroscopy aids in treating anterior cruciate ligament (ACL) injury, a significant injury in professional sports. Fluid management system pressure is set as low as possible or per the requirement to obtain a view.
COVID-19 Impact Analysis
COVID-19 has put the healthcare system under stress around the world. The pandemic has altered how medical device manufacturers and healthcare providers approach endoscopy fluid management systems. The COVID-19 pandemic affected numerous sub-specialists and procedure-related fields such as gastroenterology. A considerable number of hospitals and clinics were restructured to raise their capacity for the patient diagnosed with COVID-19. In addition, a significant proportion of these endoscopic procedures were affected due to the lockdowns, which is expected to have a negative impact on the growth of the endoscopy fluid management market.
Market Growth Factors
The increasing number of minimally invasive surgeries
Surgeries which are minimally invasive are much less traumatic than conventional open surgeries. Surgeries performed with traditional laparoscopic instruments were traumatic and complex. But in minimally invasive surgeries, laparoscopic cameras are inserted through smaller incisions, and small specialized instruments are utilized to perform the operation. The recovery is also less painful, and patients recover faster. The popularity of these surgeries are increasing due to the quicker recovery, smaller incisions, high accuracy, shorter hospital stays, and less scarring & pain. In addition, these medical displays provide even the most negligible difference in cells and tissues, ensure superior visibility, and enable rapid and precise surgery. This supports the growth of the regional market.
The rising cases of gastrointestinal cancer
It was seen that the burden of GI cancers has continued to shift towards economically developing nations which usually have fewer healthcare resources to manage the rising incidence. The number of new cases and death for each type of the five major types of GI cancers are expected to increase. This cancer is also associated with infection, tobacco smoking, diet, physical inactivity, alcohol consumption, and obesity. The increasing cases of GI cancers, especially in developing countries, will surge the utilization of endoscopy fluid management, boosting the market expansion in the projected period.
Market Restraining Factors
Alternatives to endoscopy
Patients undergoing endoscopy are generally provided with anesthetic or are mildly sedated as the procedure might be uncomfortable or painful to many patients, while almost all individuals undergoing a CT scan don't require any sedation. In addition, CT scans can be done on people of nearly every age, while most endoscopy procedures are done on adults. The painlessness and the requirement of no type of sedatives in the CT scans might make them a better alternative to endoscopy; hence the market growth for endoscopy fluid management is expected to hinder.
Product Outlook
Based on product, the endoscopy fluid management market is segmented into system and accessories. The accessories segment acquired a substantial revenue share in the endoscopy fluid management market in 2021. This is due to the usage of these accessories to provide treatment or collect tissue samples. An endoscope has a channel through which the doctor can insert tools into the patient's body. These tools include flexible forceps, which take the tissue sample; biopsy forceps which are used to remove any suspicious growth; cytology brushes which take the cell sample and suture removal forceps, which are used to remove stitches inside the body.
Application Outlook
On the basis of application, the endoscopy fluid management market is divided into laparoscopy, hysteroscopy and others. The laparoscopy segment held the highest revenue share in the endoscopy fluid management market in 2021. This is because of the increasing number of laparoscopy procedures. Many individuals are now opting for minimally invasive procedures for diagnosis and treatment. In addition, the rising geriatric population globally is further increasing the demand for endoscopy fluid management systems. These factors are anticipated to propel the segment's growth during the projected period.
End User Outlook
By end user, the endoscopy fluid management market is classified into hospital, clinics and others. The hospital segment led the endoscopy fluid management market by generating the maximum revenue share in 2021. This is due to the rising number of patient admissions for numerous surgical procedures in such healthcare settings. There is an increase in endoscopy procedures and the development of advanced hospitals. Also, many governmental bodies are now concentrating on enhancing the capacity for surgical procedures. These factors are anticipated to surge the expansion of the segment.
Regional Outlook
Region-wise, the endoscopy fluid management market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the endoscopy fluid management market in 2021. This is due to the assistance provided by these systems in maintaining precise pressure to decrease the bleeding in internal cavities during endoscopic procedures. Utilizing high-tech devices enhances treatment compliance. The region also has highly skilled medical professionals, high-tech technology, and a robust healthcare infrastructure. Also, many policies by the government to further enhance the sector is expected to increase their utilization and propel the market growth in the region.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunners in the Endoscopy Fluid Management Market. Companies such as Olympus Corporation, Stryker Corporation, Hologic, Inc. are some of the key innovators in Endoscopy Fluid Management Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
Strategies Deployed in Endoscopy Fluid Management Market
2022-Dec: Olympus came into an agreement to acquire Odin Vision, a UK-based cloud-AI endoscopy start-up. Through this acquisition, Olympus aims to strengthen its capabilities to deliver data-driven insights and advanced AI-powered solutions which can transform patient care and enhance clinical and procedural workflows.
2022-Feb: Stryker took over Vocera Communications, Inc., a company involved in digital care coordination and communication. Through this acquisition, Stryker would advance innovations and boost its digital aspirations. Additionally, both companies would work together to allow safer patient care and support their customers to enhance outcomes.
2021-Nov: Medtronic received FDA approval for PillCam Small Bowel 3 system. The PillCam SB3 integrates Medtronic's PillCam technology with Amazon logistics, integration developed to ensure both timely and precise results for patients from the convenience of their homes.
2021-Oct: Arthrex expanded its global footprint by setting up a new facility in Anderson County, United States. The new plant is expected to create 500 new jobs. The new plant reflects Arthrex's commitment to manufacturing supreme quality products in the United States and further aids Arthrex in the growth and development of new products.
2021-Jun: STERIS plc took over Cantel Medical, a provider of infection prevention products and services to dental, dialysis, endoscopy, and life sciences Customers. This acquisition would complement and broaden Steris's product and service portfolio, customers, and global.
2021-Apr: Medtronic released GI Genius, a medical device that utilizes artificial intelligence to assist clinicians to identify in real-time any potential irregularities in the colon during colonoscopies. Colonoscopies allow gastroenterologists to detect polyps and lesions that might develop into cancer as a means of screening and surveillance.
2020-Oct: Olympus Corporation launched ENDO-AID, a product that allows real-time display of automatically detected suspicious lesions. ENDO-AID works together with the newly released EVIS X1, Olympus' most advanced endoscopy system to date.
2020-Mar: KARL STORZ unveiled TELE PACK + system, a mobile, compact endoscopy system. The product is a portable video system created to integrate all the important components, consisting of the camera control unit, light source, and display needed for endoscopic diagnosis and treatment, including data management and image capture.
2018-Aug: Hologic launched the Fluent system, a fluid management system for hysteroscopic procedures across the United States. The product is developed in response to the issues faced by doctors and nurses performing hysteroscopies. The Fluent System consists of advanced technology with a modernized design for highly efficient fluid monitoring during procedures.
2018-May: Olympus unveiled DualKnife JTM, an endoscopic submucosal dissection (ESD) electrosurgical knife. The product combines submucosal injection to assist safe, efficient, and highly reliable ESD performance.
Market Segments covered in the Report:
By Application
By Product
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures